No, I appreciate that the excerpts you posted are from CYP's corporate governance ann. So it is specific to CYP, but the issue of disclosure under placements and information asymmetry isn't. That CYP corporate governance statement ann is much like clinical trial result anns and an issue I have read you highlight previously - the ann is a summary/generalisation that glosses over some nuance and specifics. In this case it's a general statement of principles, but if you delve into the specifics it contains exceptions. That is a common issue, not just a CYP issue.
CYP's full corporate governance disclosure is here: https://cynata.com/corporate-governance The Continuous Disclosure section alone is a 17 page pdf and notes the exception I posted from the Corporations Regulations in 2.2
- Forums
- ASX - By Stock
- CYP
- Screenshot(s) from Annual Report of 29 Aug 24
Screenshot(s) from Annual Report of 29 Aug 24, page-46
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
25.5¢ |
Change
-0.015(5.56%) |
Mkt cap ! $46.07M |
Open | High | Low | Value | Volume |
26.0¢ | 26.5¢ | 25.5¢ | $17.45K | 67.52K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10248 | 25.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 3618 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10248 | 0.255 |
3 | 30800 | 0.250 |
1 | 10000 | 0.245 |
2 | 10000 | 0.240 |
1 | 2130 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 3618 | 1 |
0.270 | 50000 | 1 |
0.275 | 65271 | 2 |
0.280 | 109404 | 4 |
0.290 | 36000 | 1 |
Last trade - 13.10pm 09/10/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online